Mumbai: Indoco Remedies Ltd. has announced the final approval of Allopurinol Tablets USP 200 mg through its Abbreviated New ...

Indoco Remedies rose 1.28% to Rs 245.80 after the company announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug ...

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets ...

A new study published in the journal of Arthritis Care & Research showed that in individuals with gout, usage of Febuxostat ...

Indoco Remedies receives US FDA final approval to market allopurinol tablets USP 200 mg: Our Bureau, Mumbai Friday, May 23, 2025, 12:30 Hrs [IST] Indoco Remedies Ltd., a fully int ...

On Monday, 2531 stocks advanced, 1565 declined and 177 remained unchanged on Bombay Stock Exchange with advance decline ratio of 1.61 indicating a positive closing in the broader market.

Current first-line therapies like allopurinol and febuxostat can be very effective, but some patients – roughly 1% according to FDA estimates – don’t get the hoped-for benefit, while others ...

GPT Healthcare Limited reported its financial result for the fourth quarter ended Mar 31, 2025. During the Q4 FY25, the total ...

The board of directors of Sharda Motor Industries Limited has approved the issuance of Bonus Shares to the Shareholders of ...